Roxwood Medical Expands Its Microcross Catheter Platform With The Addition Of The Micro14es (Extra Support) Catheter

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Roxwood Medical, Inc. announced today the expansion of its successful MicroCross™ Catheter platform with the addition of the Micro14es (extra support) catheter. Micro14es is an extension of the Micro14 catheter, specifically designed for complex peripheral and coronary disease. Designed in collaboration with key opinion leaders, the Micro14es provides enhanced guidewire support through challenging and tortuous anatomy with an extra supportive tip profile for greater pushability when crossing the target lesion.

“The Micro14 and Micro18 have become a core part of our Critical Limb Ischemia toolkit and the Micro14es is a welcome addition. The team at Roxwood Medical continues to improve and innovate an already impressive portfolio of catheters to help us treat patients with such complex disease.”

Compatible with Roxwood Medical’s CenterCross^® Catheter, the MicroCross platform is comprised of an ultra-low profile shaft featuring variable pitch braid technology and a state-of-the-art lubricious coating. These features allow for superior trackability and guidewire support while accessing tortuous regions of the coronary and peripheral vasculature.

“I was impressed with how easily the new Micro14es was able to navigate small tortuous vessels in the patient’s foot,” commented Dr. Jihad Mustapha of Metro Hospital in Wyoming, MI. “The Micro14 and Micro18 have become a core part of our Critical Limb Ischemia toolkit and the Micro14es is a welcome addition. The team at Roxwood Medical continues to improve and innovate an already impressive portfolio of catheters to help us treat patients with such complex disease.”

Roxwood Medical President & CEO, Mehrdad Farhangnia, added, “After the tremendous feedback we have received from clinicians for our Micro14 and Micro18 catheters, we’re excited about the addition of Micro14es. It underscores our commitment to the evolution of our technology for treating patients with Complex PCI and Critical Limb Ischemia. Beyond the MicroCross, CenterCross and MultiCross^® Catheters, we have a rich pipeline of other new tools we plan to bring to the US market in 2016.”

About Roxwood Medical, Inc.
Roxwood Medical (www.roxwoodmedical.com) is a privately held medical device company focused on empowering physicians through the design and development of innovative and cost-effective catheter platforms for advanced cardiovascular disease. To date, Roxwood has been granted US FDA 510(k) clearance for the MultiCross, CenterCross, and MicroCross Catheter platforms.